Your browser doesn't support javascript.
loading
Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma.
Black, Christopher M; Hanna, Glenn J; Wang, Liya; Ramakrishnan, Karthik; Goto, Daisuke; Turzhitsky, Vladimir; Hair, Gleicy M.
Afiliación
  • Black CM; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, NJ, United States.
  • Hanna GJ; Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
  • Wang L; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, NJ, United States.
  • Ramakrishnan K; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, NJ, United States.
  • Goto D; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, NJ, United States.
  • Turzhitsky V; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, NJ, United States.
  • Hair GM; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, NJ, United States.
Front Oncol ; 13: 1240947, 2023.
Article en En | MEDLINE | ID: mdl-37529689
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza